NCT02736643

Brief Summary

Lung cancer is one of the leading causes of cancer-related death in Taiwan. Early diagnosis of lung cancer may improve cancer survival. Low-dose computed tomography (LDCT) was thought to be the best screening tool for lung cancer. However, there is growing concerns about radiation exposure, high cost, and high rate of false-positive screening result. Epidemiology data for LDCT screening in Taiwan is lacking. National Taiwan University Hospital Chu-Tung Branch (NTUHCT) initiated the lung cancer screening by LDCT since June 2015. Many people can get the LDCT screening with affordable price with the subsidy from enterprise donation. The purpose of this study is establishing local epidemiological result via telephone follow-up and patients' medical records retrospectively.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,334

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2016

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 10, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 13, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

January 17, 2019

Status Verified

January 1, 2019

Enrollment Period

1.7 years

First QC Date

April 10, 2016

Last Update Submit

January 15, 2019

Conditions

Lung Cancer

Keywords

LDCT, screening

Outcome Measures

Primary Outcomes (1)

  • Abnormal lung finding detection rate

    Abnormal lung finding detection rate calculated as (patients with abnormal finding from LDCT / total enrollments).

    one month

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

self pay the LDCT in National Taiwan University Hospital Chu-Tung Branch

You may qualify if:

  • self pay the LDCT in National Taiwan University Hospital Chu-Tung Branch

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Ding-Cheng Chan, MD, PhD

    National Taiwan University Hospital Chu-Tung Branch

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Target Duration
52 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2016

First Posted

April 13, 2016

Study Start

April 1, 2016

Primary Completion

December 28, 2017

Study Completion

December 31, 2018

Last Updated

January 17, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share